Study Stopped
Because of COVID-19, we cann't carry out recruiting according to the original plan
The Cost of Obsessive-compulsive Disorder (OCD) in China
OCD
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2019
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedStudy Start
First participant enrolled
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedNovember 17, 2020
November 1, 2020
9 months
December 30, 2019
November 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
obsessive-compulsive disorder related costs in China
Estimating the direct and indirect Costs of Chinese OCD based on prevalence from a social perspective
1 year
Secondary Outcomes (2)
Direct costs and indirect costs of consumed resources
1 year
other costs directly associated with OCD
1 year
Study Arms (1)
Participants
OCD patients come from 13 hospitals located in the north, south, east and west of China
Interventions
Eligibility Criteria
patients with obsessive-compulsive disorder are recruited from both outpatient clinics and inpatient departments
You may qualify if:
- primarily diagnosed OCD meet DSM-5 critera
- years old
- Get informed consent from patients
You may not qualify if:
- Concurrent neuropsychiatric diseases such as schizophrenia, which severely interfere with treatment costs
- Drug abuser
- Unable to understand the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai Mental Health Centerlead
- Capital Medical Universitycollaborator
- Peking University Sixth Hospitalcollaborator
- First Affiliated Hospital Xi'an Jiaotong Universitycollaborator
- Shandong Provincial Hospitalcollaborator
- Qingdao Mental Health Centercollaborator
- the First Psychiatric Hospital of Harbincollaborator
- Qiqihar Medical Universitycollaborator
- The Second Affiliated Hospital of Xinxiang Medical Collegecollaborator
- Seventh People's Hospital of Hangzhoucollaborator
- Guangji Hospital Affiliated to Soochow Universitycollaborator
- First Affiliated Hospital of Kunming Medical Universitycollaborator
- Brain Hospital Affiliated to Guangzhou Medical Universitycollaborator
Study Sites (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wang Zhen, PhD,MD
Shanghai Mental Health Center
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- vice-president
Study Record Dates
First Submitted
December 30, 2019
First Posted
January 2, 2020
Study Start
January 2, 2020
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
November 17, 2020
Record last verified: 2020-11